title: Decreased peripheral 3,5,3'-triiodothyronine (T3) production from thyroxine (T4): a syndrome of impaired thyroid hormone activation due to transport inhibition of T4- into T3-producing tissues.
abstract: T4, rT3, and T3 kinetic studies have been performed in a T4-substituted female who showed an increased serum T4/T3 ratio and substantially increased rT3 serum levels in the presence of normal serum thyroid hormone binding properties. The kinetic studies were performed to discriminate between T4 transport inhibition into plasma T3-producing tissues and inhibition of extrathyroidal T4 to T3 conversion. The principal findings were that both T4 and rT3 transport were inhibited into the rapid equilibrating pool (REP), which mainly consists of the liver. The plasma T3 production rate was decreased. Despite an elevated serum free T4 level, serum TSH was elevated, pointing to T4 transport inhibition at the level of the thyrotroph as well. Transport of T4 and rT3 was normal to the slowly equilibrating pool, whereas no transport inhibition of T3 was found to either pool. Because T4 into T3 conversion efficiency in the REP (the main source of plasma T3 production) was normal, it was concluded that the lowered T3 production in the subject was caused by transport inhibition of T4 into the liver. Although the occurrence of the syndrome is rare, its significance is of general importance, in that it shows that transport of thyroid hormone may vary at the tissue level. Furthermore, as T3 is the principal biologically active thyroid hormone, regulation of transport of T4 into the REP may play a (patho)physiological role in the ultimate determination of thyroid hormone activity in the tissues.
authors.affiliation: Department of Internal Medicine, University Hospital Dijkzigt, Rotterdam, The Netherlands.
authors.forename: G
authors.initials: G
authors.lastname: Hennemann
authors.forename: R A
authors.initials: RA
authors.lastname: Vos
authors.forename: M
authors.initials: M
authors.lastname: de Jong
authors.forename: E P
authors.initials: EP
authors.lastname: Krenning
authors.forename: R
authors.initials: R
authors.lastname: Docter
mesh_terms: D000368:Aged; D001692:Biological Transport / Q000187:drug effects; D002478:Cells, Cultured; D005260:Female; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008875:Middle Aged; D011441:Propylthiouracil / Q000494:pharmacology; D012016:Reference Values; D012867:Skin / Q000378:metabolism / Q000473:pathology; D013577:Syndrome; D013963:Thyroid Hormones / Q000502:physiology*; D013974:Thyroxine / Q000378:metabolism*; D014284:Triiodothyronine / Q000096:biosynthesis*
chemical_list: D013963:Thyroid Hormones; D014284:Triiodothyronine; D011441:Propylthiouracil; D013974:Thyroxine